EYE-D INNOVATION APS

Their core work

EYE-D Innovation is a Danish private company working at the intersection of additive manufacturing (3D printing) technology and its real-world applications in medical and industrial contexts. Their technical work centers on ceramic and multi-material components produced through AM processes, particularly for personalized medical use — implants, prosthetics, and similar patient-specific devices. Beyond the engineering, they engage with the broader innovation ecosystem: their second project examined how additive manufacturing value chains develop under Responsible Research and Innovation (RRI) principles, suggesting they help organizations navigate both the technical and the societal dimensions of deploying AM technologies. They operate as a specialist contributor in European research consortia rather than a project lead, likely bringing commercial market perspective and innovation translation capacity to otherwise research-heavy teams.

What they specialise in

How they've shifted over time

In their first H2020 project (2015–2018), EYE-D was deep in hands-on technical territory — ceramic materials, multi-material processing, and additive manufacturing methods for personalized medical components. By 2018–2021, their focus shifted decisively toward the systemic and societal layer: how AM value chains form, who controls them, and how innovation in this space can be made more responsible. This trajectory — from material science application toward innovation governance — suggests a company that started as a technical implementer and has matured into one that can also advise on the broader industrial and policy context of AM adoption.

EYE-D appears to be moving toward innovation consultancy and systemic analysis of AM ecosystems, making them a stronger fit for projects that need both technical grounding and responsible innovation framing rather than pure engineering execution.

How they like to work

EYE-D has participated in both projects as a consortium partner, never as coordinator, which is consistent with a specialist or commercial contributor role rather than a project management function. Despite only two projects, they have accumulated 23 unique partners across 13 countries — an average consortium size of roughly 11–12 organizations per project — indicating they operate in large, multi-stakeholder European consortia. There is no evidence of repeated partnerships with the same organizations, suggesting they bring targeted expertise to diverse teams rather than anchoring a stable research network.

EYE-D has collaborated with 23 distinct organizations across 13 countries through just two projects, reflecting involvement in large, geographically diverse European consortia. Their network spans well beyond Denmark, indicating comfort operating in multilateral research environments despite their small footprint as a company.

What sets them apart

EYE-D is one of the few private Danish companies active in H2020 additive manufacturing research at the ceramic and medical application end of the spectrum — an area dominated by universities and research institutes. Their combination of technical AM expertise (ceramic, multi-material) and RRI/value chain analytical capacity means they can bridge the gap between laboratory-stage technology and market-ready deployment in regulated sectors like medtech. For consortium builders, they offer a commercial perspective that most research-heavy AM consortia lack.

Highlights from their portfolio

• CerAMfacturing
  Largest project by EC funding (EUR 621,437) and the clearest signal of EYE-D's core technical capability — ceramic and multi-material additive manufacturing for personalized medical components, a highly specific and commercially valuable niche.
• I AM RRI
  Signals a strategic pivot toward responsible innovation governance in AM, making EYE-D relevant to policy-oriented and societal-impact projects well beyond their original technical focus.